Human MxA is an alpha/beta interferon-inducible intracytoplasmic protein th
at mediates antiviral activity against several RNA viruses. We had previous
ly shown that overexpression of the hepatitis B virus (HBV) capsid led to s
elective downregulation of MxA gene expression, suggesting a mechanism by w
hich the virus escapes from the host defense system (O. Rosmorduc, Ef. Sirm
a, P. Soussan, E. Gordien, P. Lebon, M. Horisberger, C. Brechot and D. Krem
sdorf, J Gen. Virol. 80:1253-1262, 1999), In the present study, we investig
ated the antiviral activity of MxA protein against HBV. MxA-expressing HuH7
clones were established and transiently transfected with HBV, and viral re
plication was then studied. Viral protein secretion was profoundly reduced
in MxA-expressing clones by 80% for HBV surface antigen (HBsAg) and 70% for
HBV e antigen (HBeAg). The levels of intracytoplasmic HBsAg and HBeAg were
reduced by about 80 and 50% in the two MxA-positive clones tested. A nearl
y complete disappearance of HEV DNA replicative intermediates was observed
in MxA-expressing clones. Although the expression of total viral RNAs was n
ot modified, two- to fourfold reductions in HBV cytoplasmic RNAs were found
in MxA-expressing clones. This suggests the inhibition of HBV replication
at a posttranscriptional level. Indeed, using the well-characterized posttr
anscriptional regulation element (PRE) reporter system, we were able to dem
onstrate a marked reduction (three- to eightfold) in the nucleocytoplasmic
export of unspliced RNA in MxA-expressing clones. In addition, MxA protein
did not interact with HBV nucleocapsid or interfere with HBV nucleocapsid f
ormation. Our results show an antiviral effect of MxA protein on a DNA viru
s for the first time, MxA protein acts, at least in part, by inhibiting the
nucleocytoplasmic export of viral mRNA via the PRE sequence.